EPROSARTAN

SynDRA canonical compound SYN0001983 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	AGTR1
Mechanism of action	angiotensin receptor antagonist
Indication	hypertension
Disease area	cardiology

All known targets

SKF-108566
eprosartan mesylate
eprosartan mesilate
SK&F-108566
SK-108566
Teveten
F 108566
UNII-2KH13Z0S0Y
(E)-4-((2-Butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid
(E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid
CHEMBL813
2KH13Z0S0Y
CHEBI:4814
4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
(E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid
Teveten (TN)
Eprosartan (USAN/INN)
Eprosartan [USAN:BAN:INN]
(4-carboxybenzyl)imidazole-5-acrylic acid
(E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid
4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid
[3H]eprosartan
4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid
[3H]-eprosartan
4-({2-butyl-5-[(1E)-2-carboxy-2-(thiophen-2-ylmethyl)eth-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid
NCGC00164557-01
Eprozar
Eprosartan [USAN:INN:BAN]
SR-05000001450
HSDB 7521
[3H]SK&F 108566
EPROSARTAN [MI]
EPROSARTAN [INN]
EPROSARTAN [HSDB]
EPROSARTAN [USAN]
EPROSARTAN [VANDF]
SCHEMBL4025